Vivimed Labs Limited

Vivimed Labs Limited (VIVIMEDLAB) is a micro-cap Healthcare company valued at ₹54 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Vivimed Labs Limited last traded at ₹6.71, modestly down 1.90% on the day.

Recent developments

On 2026-03-31, the company reported a net loss of ₹175 crore for its latest financial year, marking a significant widening of the loss compared to previous years. The latest quarter ended on the same date, with revenue at ₹12 crore and a net loss of ₹146 crore, showing a sharp decline from the year-ago quarter.

Financial performance

The company's business is deteriorating, with annual revenue falling 22.3% over three years and 21.6% over five years. The latest quarter saw revenue drop 53.8% compared to the same quarter a year earlier, while the net loss widened sharply from ₹6 crore to ₹146 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -0.21 times book value.

Things to watch

The company reported a net loss of ₹175 crore in its latest financial year, with the loss widening from ₹45 crore to ₹175 crore over three years. The latest quarter saw a net loss of ₹146 crore, a sharp increase from ₹6 crore in the same quarter a year earlier. The stock is 80.6% below its 52-week high.

Where it stands

The company's financial performance has worsened significantly, with a net loss of ₹175 crore in the latest financial year and a net loss of ₹146 crore in the latest quarter. The stock is 80.6% below its 52-week high, highlighting the extent of the decline.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.